Clinical Trial

PURI-PRO - Symptoms Impact and eHealth Intervention for Menopausal Women With Urinary Incontinence

Study acronym: PURI-PRO
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 15, 2025 (before its estimated December 18, 2025 completion). Its status may not reflect the trial's current state.
Summary
Urinary Incontinence (UI) is a public health problem that disrupts the Quality of Life, Productivity, Social Isolation and Sexual Function; its prevalence in peri- and postmenopausal women is around 30-40%. UI remains underreported and undertreated. Previous eHealth interventions have been efficacious with women. Thus, PURI-PRO (Portuguese Urinary Incontinence Project) (FCT Grant 2020.05710.BD) entailed a low-cost 8-week eHealth cognitive-behavioural multidisciplinary intervention aimed at reducing UI symptoms' severity through Pelvic Floor Muscle Training, development of healthy bladder habits, and promotion of adherence to exercises, realistic UI-beliefs, and functional coping strategies. Urinary incontinence symptom severity, frequency and its impact on quality of life, beliefs and strategies regarding urinary incontinence, self-esteem, social isolation, and adherence to pelvic floor muscle excercises were evaluated.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2024-07-26; most recent amendment 2025-12-06.
Status change: Recruiting → Active, Not Recruiting 2025-12-06
Status change: Active, Not Recruiting → Recruiting 2025-03-12
Trial Details
NCT Number NCT06527638
Lead Sponsor ISPA - Instituto Universitario de Ciencias Psicologicas, Sociais e da Vida
Collaborators: Fundação para a Ciência e a Tecnologia
Conditions Urinary Incontinence
Enrollment 80 participants
Start Date 2025-04-22
Primary Completion 2025-12-18 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-15